While we did not observe NKG2D ligand expression on any lymphocytes in the DEN model of HCC, we cannot rule out that this is occurring for a short period of time during tumor progression, despite it being no longer present at end point. The gene discussed is KLRK1; the disease is hepatocellular carcinoma.